The Affiliated Hospital of Charlotte University is located in Berlin, Germany, with a long history of more than 300 years. The hospital has long enjoyed a high reputation for its outstanding medical treatment, medical research and medical teaching.
Half of the winners of the German Nobel Prize in Medicine and Physiology came from the hospital, including Emil von Behring, the pioneer of diphtheria conquest, Robert Koch, the founder of world pathogenic bacteriology, Paul Ehrlich, the actual founder of humoral immunity and the precursor of chemotherapy, Werner Formann, the inventor of cardiac catheters, etc. The hospital consists of four hospital districts, distributed in different regions of Berlin, with a total area of 607200 square meters, more than 15000 doctors, nurses and logistics staff, more than 100 specialist clinics and research institutes, and 17 specialist centers. Charit é Hospital receives 140000 inpatients and 600000 outpatients every year, and operates more than 7000 sets every month. In 2011, the hospital was rated as "the best general hospital in Germany" by Focus. In 2012 and 2013, the comprehensive ranking of all German hospitals ranked first. Its strength and influence can be seen from several major events in recent years.
As the largest university hospital in Europe, Charlotte Hospital has the internationally recognized top level medical technology, cutting-edge medical research achievements and the latest scientific research equipment, and gathers the world's top medical experts. More than 60 specialties carry out diagnosis, treatment and research on specialized diseases, and highly specialized expert teams form interdisciplinary expert teams based on patients' conditions to develop and implement personalized treatment plans for each patient, so as to ensure that patients get the best diagnosis and treatment results.
Adult specialties mainly include oncology, cardiovascular medicine, orthopedics, dermatology, endocrinology, metabolism, weight loss surgery, otorhinolaryngology, gastroenterology, hepatology, gynecology, lung, nephrology, neurosurgery, obstetrics, ophthalmology, oral and maxillofacial surgery, plastic surgery, infectious diseases, rheumatism and immunology, general surgery, trauma surgery, and urology.
The pediatrics of Charite Hospital covers almost all types of diseases of infants and adolescents, and its treatment technology for rare diseases of children is second to none in Europe. Children's characteristic specialties include pediatric cardiology, pediatric neurosurgery, pediatric surgery, pediatric tumor and blood diseases, pediatric endocrinology, pediatric digestion, pediatric allergy and immunity, rheumatism, pediatric kidney and lung diseases, etc.
In addition to providing high standard diagnosis and treatment for all patients, Charlotte Hospital is at the world's leading level in many specialized fields.
Orthopedics and Trauma Surgery Center
The Orthopedics and Trauma Surgery Center, headed by Dr. Haas, an internationally renowned medical professor, enjoys a high international reputation in the treatment of spinal surgery, hip and knee replacement, difficult joints and bone diseases, and sports injuries. So far, the center has completed nearly 100000 hip and knee replacement operations. Another major advantage of the Orthopedic Center is the revision of artificial joints after loosening, infection or failure of artificial joint replacement. It is an internationally renowned artificial joint revision treatment center. In addition to artificial joint replacement, the center is good at arthroscopic surgery and has successively carried out minimally invasive knee, hip, ankle, shoulder and elbow arthroscopic surgery to treat various types of joint diseases and sports injuries such as knee meniscus, anterior and posterior cruciate ligaments and rotator cuff.
Comprehensive Cancer Treatment Center
Charit é Hospital Comprehensive Cancer Center (CCCC) is an internationally renowned cancer treatment center and a leading member of the European Cancer Society and the German Cancer Society. The center has the most advanced cancer treatment equipment in Europe. The interdisciplinary cancer expert group formed by the center is the key to ensure the best diagnosis and treatment effect for patients. The expert group gathers authoritative experts from different specialties to discuss the condition of each cancer patient and provide customized treatment plan. The attending physician is responsible for communicating with the patient on the treatment plan. The center regularly measures and controls the diagnosis and treatment quality of the expert group through long-term follow-up of discharged patients.
Neurosurgery Center
The Affiliated Hospital of Charlotte University has a long history of neurosurgery Led by Professor Vajcox, he is particularly good at treating the following diseases:
Cerebrovascular disease Cerebrovascular aneurysm Intracranial arteriovenous malformation AVM Cerebral ischemia (bypass surgery) Brain tumor Glioma astrocytoma Brain metastasis Jugular glomus tumor Acoustic neuroma Vestibular neurilemmoma Meningioma Pituitary adenoma Chordoma
Pediatric Center
Charlotte Hospital has the largest and most famous pediatric disease treatment center in Europe, which enjoys a high international reputation in pediatric tumors and surgery. The Pediatric Center combines pediatric surgery, pediatric anesthesia, pediatric radiology and pediatric severe medicine, and is especially good at treating pediatric leukemia, complex congenital defects such as malformations, diaphragmatic hernia, intestinal neuron abnormalities, chest wall deformation such as pectus excavatum or chicken chest, lung cancer such as pulmonary cyst, congenital and acquired kidney and urinary tract diseases.
In January 2012, the Pediatric Center of Charlotte University Hospital led the world's largest research project on the treatment and prevention of recurrence of the most common childhood malignant disease, acute lymphoblastic leukemia (IntReALL). Every year, about 700 children and adolescents in Germany suffer from acute lymphoblastic leukemia, of which 70% suffer from relapse. Through intensive combination chemotherapy and stem cell transplantation, the survival rate has increased from 20% in the 1970s to 80% today. A total of 23 research teams participated in the IntReALL project, which was led by the Pediatric Center of Charlotte University. The project aims to help children with acute lymphoblastic leukemia find the most effective treatment to cure and prevent recurrence through the research results of the project.
